<?xml version="1.0" encoding="UTF-8"?>
<document id="27612429">
	<sentence id="s1" text="Recent evidence suggests that ARS genes may participate in a wide array of cellular processes, and may contribute to the pathology of autoimmune disease, cancer, and other diseases.">
		<entity id="s1.e1" charOffset="30-33"
			type="GENE" text="ARS" ontology_id="57152"/>
		<entity id="s1.e2" charOffset="154-160"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Several studies have suggested a role for the glutamyl prolyl tRNA synthetase (EPRS) in breast cancers, although none has identified any underlying mechanism about how EPRS contributes to carcinogenesis.">
		<entity id="s2.e1" charOffset="79-83"
			type="GENE" text="EPRS" ontology_id="2058"/>
		<entity id="s2.e2" charOffset="95-101"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="In this study, we identified EPRS as upregulated in estrogen receptor positive (ER+) human breast tumors in the TCGA and METABRIC cohorts, with copy number gains in nearly 50% of samples in both datasets.">
		<entity id="s3.e1" charOffset="29-33"
			type="GENE" text="EPRS" ontology_id="2058"/>
		<entity id="s3.e2" charOffset="98-104"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="EPRS expression is associated with reduced overall survival in patients with ER+ tumors in TCGA and METABRIC datasets.">
		<entity id="s4.e1" charOffset="0-4"
			type="GENE" text="EPRS" ontology_id="2058"/>
		<entity id="s4.e2" charOffset="81-87"
			type="HP" text="tumors" ontology_id="HP_0002664"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
	</sentence>
	<sentence id="s5" text="We demonstrated the necessity of EPRS for proliferation of tamoxifen-resistant ER+ breast cancer, but not ER- breast cancer cells.">
		<entity id="s5.e1" charOffset="33-37"
			type="GENE" text="EPRS" ontology_id="2058"/>
		<entity id="s5.e2" charOffset="90-96"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s5.p1" e1="s5.e1"
		    e2="s5.e2" pgr="false"/>
	</sentence>
	<sentence id="s6" text="Finally, we constructed a causal gene network based on over 2500 ER+ breast tumor samples to build up an EPRS-estrogen signaling pathway.">
		<entity id="s6.e1" charOffset="76-81"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s6.e2" charOffset="105-109"
			type="GENE" text="EPRS" ontology_id="2058"/>
		<pair id="s6.p1" e1="s6.e1"
		    e2="s6.e2" pgr="false"/>
	</sentence>
	<sentence id="s7" text="EPRS and its regulated estrogenic gene network may offer a promising alternative approach to target ER+ breast cancers that are refractory to current anti-estrogens">
		<entity id="s7.e1" charOffset="0-4"
			type="GENE" text="EPRS" ontology_id="2058"/>
		<entity id="s7.e2" charOffset="111-117"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s7.p1" e1="s7.e1"
		    e2="s7.e2" pgr="false"/>
	</sentence>
</document>
